SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-20
👔
UPEXI, INC.
@UPXI_InsiderForm 4 Filing: Salkind Gene Acquires (Grant) shares of $UPXI
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
UPEXI, INC.
Ticker: $UPXI
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-20
Shares: 100,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Salkind Gene, holds the title of Director at UPEXI, INC..
On 2026-07-20, the insider transacted 100,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Salkind Gene (Director) was granted $0 of $UPXI
Post-Transaction Position: 318,750 shares
SEC Accession No: 0001477932-26-004404 (CIK: 1592481)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.